Does Rallies show Form 4 insider transactions for PHR?

Yes. Rallies tracks PHR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PHR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PHR. It does not provide personalized investment advice.

PHR (Phreesia, Inc.) Stock Analysis - Insider Trades

Phreesia, Inc. (PHR) is a publicly traded Healthcare sector company. As of May 21, 2026, PHR trades at $8.85 with a market cap of $560.91M and a P/E ratio of 219.88. PHR moved -3.65% today. Year to date, PHR is -48.31%; over the trailing twelve months it is -65.28%. Its 52-week range spans $7.77 to $32.76. Analyst consensus is buy with an average price target of $14.43. Rallies surfaces PHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PHR stock inside the company?

Recent PHR insider activity includes Hoffman Allison C sold 6.18K, Hui Yvonne sold 1.33K, Hui Yvonne sold 10.06K, Hoffman Allison C sold 14.48K, and Linetsky David sold 8.33K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PHR Key Metrics

Key financial metrics for PHR
Metric	Value
Price	$8.85
Market Cap	$560.91M
P/E Ratio	219.88
EPS	$0.04
Dividend Yield	0.00%
52-Week High	$32.76
52-Week Low	$7.77
Volume	0
Avg Volume	0
Revenue (TTM)	$480.59M
Net Income	$2.31M
Gross Margin	0.00%

Recent PHR Insider Trades

Hoffman Allison C sold 6.18K (~$55.95K) on Apr 20, 2026.
Hui Yvonne sold 1.33K (~$12.31K) on Apr 17, 2026.
Hui Yvonne sold 10.06K (~$91.37K) on Apr 16, 2026.
Hoffman Allison C sold 14.48K (~$116.88K) on Apr 10, 2026.
Linetsky David sold 8.33K (~$67.24K) on Apr 10, 2026.

Latest PHR News

Phreesia Downgraded by Four Brokers, Cuts 2027 Outlook by $35M–$39M — Mar 31, 2026
Phreesia Appoints Jon Kessler to Board of Directors Effective February 2026 — Feb 23, 2026
Phreesia Faces Securities Probe After 25% Share Plunge Post-Q3 Guidance Cut — Feb 19, 2026

PHR Analyst Consensus

16 analysts cover PHR: 0 strong buy, 10 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.43.

Common questions about PHR

Who is trading PHR stock inside the company?: Recent PHR insider activity includes Hoffman Allison C sold 6.18K, Hui Yvonne sold 1.33K, Hui Yvonne sold 10.06K, Hoffman Allison C sold 14.48K, and Linetsky David sold 8.33K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PHR?: Yes. Rallies tracks PHR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PHR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PHR. It does not provide personalized investment advice.